PhenixFIN Corp — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that PhenixFIN Corp filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $4.16M | Dec 12, 2025 |
| FY2025 | Sep 30, 2024 | $18.62M | Dec 12, 2025 |
| FY2025 | Sep 30, 2023 | $26.92M | Dec 12, 2025 |
| FY2024 | Sep 30, 2022 | ($6.11M) | Dec 17, 2024 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | ($67.33M) | Dec 12, 2025 |
| FY2025 | Sep 30, 2024 | $16.10M | Dec 12, 2025 |
| FY2025 | Sep 30, 2023 | ($20.71M) | Dec 12, 2025 |
| FY2024 | Sep 30, 2022 | ($29.30M) | Dec 17, 2024 |
| FY2023 | Sep 30, 2021 | $95.13M | Dec 22, 2023 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $316.91M | Dec 12, 2025 |
| FY2025 | Sep 30, 2024 | $302.75M | Dec 12, 2025 |
| FY2024 | Sep 30, 2023 | $239.69M | Dec 17, 2024 |
| FY2023 | Sep 30, 2022 | $218.87M | Dec 22, 2023 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $156.14M | Dec 12, 2025 |
| FY2025 | Sep 30, 2024 | $142.44M | Dec 12, 2025 |
| FY2024 | Sep 30, 2023 | $92.99M | Dec 17, 2024 |
| FY2023 | Sep 30, 2022 | $98.03M | Dec 22, 2023 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $160.77M | Dec 12, 2025 |
| FY2025 | Sep 30, 2024 | $160.31M | Dec 12, 2025 |
| FY2025 | Sep 30, 2023 | $146.71M | Dec 12, 2025 |
| FY2025 | Sep 30, 2022 | $120.85M | Dec 12, 2025 |
| FY2024 | Sep 30, 2021 | $143.69M | Dec 17, 2024 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | ($543.87M) | Dec 12, 2025 |
| FY2025 | Sep 30, 2024 | ($544.60M) | Dec 12, 2025 |
| FY2025 | Sep 30, 2023 | ($548.11M) | Dec 12, 2025 |
| FY2024 | Sep 30, 2022 | ($554.56M) | Dec 17, 2024 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $7.30M | Dec 12, 2025 |
| FY2025 | Sep 30, 2024 | $67.60M | Dec 12, 2025 |
| FY2024 | Sep 30, 2023 | $6.00M | Dec 17, 2024 |
| FY2023 | Sep 30, 2022 | $22.80M | Dec 22, 2023 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | 2 | Dec 12, 2025 |
| FY2025 | Sep 30, 2024 | 9 | Dec 12, 2025 |
| FY2025 | Sep 30, 2023 | 12 | Dec 12, 2025 |
| FY2024 | Sep 30, 2022 | (2) | Dec 17, 2024 |
| FY2023 | Sep 30, 2021 | 0 | Dec 22, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | 2 | Dec 12, 2025 |
| FY2025 | Sep 30, 2024 | 9 | Dec 12, 2025 |
| FY2025 | Sep 30, 2023 | 12 | Dec 12, 2025 |
| FY2024 | Sep 30, 2022 | (2) | Dec 17, 2024 |
| FY2023 | Sep 30, 2021 | 0 | Dec 22, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | 2.00M | Dec 12, 2025 |
| FY2025 | Sep 30, 2024 | 2.02M | Dec 12, 2025 |
| FY2024 | Sep 30, 2023 | 2.07M | Dec 17, 2024 |
| FY2024 | Sep 30, 2022 | 2.10M | Dec 17, 2024 |
| FY2024 | Sep 30, 2021 | 2.52M | Dec 17, 2024 |
| FY2024 | Sep 30, 2020 | 2.72M | Dec 17, 2024 |
| FY2023 | Sep 30, 2019 | 2.72M | Dec 22, 2023 |